Adrenal Function in Patients With Newly Diagnosed Lung Cancer

NCT00364624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2009-01-16

No results posted yet for this study

Summary

Patients with newly diagnosed lung cancer may have hypofunction of the adrenal cortex either from tumour metastasis or other mechanisms. Since lung cancer patient may have to undergo stressful investigation and treatments, undetected hypofunction of the adrenal cortex may be hazardous. Knowledge of the size of the problem may help determine whether routine check is warranted.

Conditions

Sponsors & Collaborators

  • Princess Margaret Hospital, Hong Kong

    lead OTHER_GOV

Principal Investigators

  • Wai C YU, MBBS · Princess Margaret Hospital, Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2008-04-30
Completion
2008-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00364624 on ClinicalTrials.gov